| 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 核苷类产品(元) | 194,427,528.82 | 87,625,881.48 | 134,471,920.59 | 73,278,894.27 |
| 医药中间体(元) | 225,170,005.87 | 176,557,028.67 | 155,267,633.29 | 61,798,330.51 |
| 其他产品(元) | 180,358,291.51 | 47,694,507.37 | 165,558,308.31 | 87,219,827.02 |
| 其他业务(元) | - | - | - | 7,082,129.82 |
| 营业成本(元) | ||||
| 核苷类产品(元) | 154,364,544.29 | 69,110,144.82 | 109,233,819.56 | 59,682,975.24 |
| 医药中间体(元) | 205,946,631.49 | 147,445,812.54 | 124,778,920.41 | 50,971,369.81 |
| 其他产品(元) | 179,015,839.61 | 47,173,476.46 | 154,817,643.89 | 72,393,810.49 |
| 其他业务(元) | - | - | - | 5,944,117.15 |
| 毛利(元) | ||||
| 核苷类产品(元) | 40,062,984.53 | 18,515,736.66 | 25,238,101.03 | 13,595,919.03 |
| 医药中间体(元) | 19,223,374.38 | 29,111,216.13 | 30,488,712.88 | 10,826,960.70 |
| 其他产品(元) | 1,342,451.90 | 521,030.91 | 10,740,664.42 | 14,826,016.53 |
| 其他业务(元) | - | - | - | 1,138,012.67 |
| 毛利率(%) | ||||
| 核苷类产品(%) | 20.61 | 21.13 | 18.77 | 18.55 |
| 医药中间体(%) | 8.54 | 16.49 | 19.64 | 17.52 |
| 其他产品(%) | 0.74 | 1.09 | 6.49 | 17.00 |
| 其他业务(%) | - | - | - | 16.07 |
| 收入构成(%) | ||||
| 核苷类产品(%) | 32.41 | 28.10 | 29.53 | 31.95 |
| 医药中间体(%) | 37.53 | 56.61 | 34.10 | 26.94 |
| 其他产品(%) | 30.06 | 15.29 | 36.36 | 38.02 |
| 其他业务(%) | - | - | - | 3.09 |
| 毛利构成(%) | ||||
| 核苷类产品(%) | 66.08 | 38.46 | 37.97 | 33.66 |
| 医药中间体(%) | 31.71 | 60.46 | 45.87 | 26.81 |
| 其他产品(%) | 2.21 | 1.08 | 16.16 | 36.71 |
| 其他业务(%) | - | - | - | 2.82 |